Innovative Transfer of CAR T-Cell Technologies
Transform your cancer treatment capabilities with our comprehensive CAR T-cell technology transfer, training, and implementation services for hospitals worldwide.
Our Technology Transfer Solutions
Advanced CAR T-cell Vectors
Our precision-engineered CAR T-cell vectors utilize cutting-edge biotechnology to deliver superior efficacy and safety in cancer treatment protocols.
Learn more about our CAR T Therapy and Immunotherapy solutions.
Seamless Technology Transfer
We specialize in comprehensive CAR T-cell therapy technology transfer, providing reliable and scalable solutions for advanced cellular therapies.
Explore our Hospital Partnerships and About Us.
Comprehensive Training Program
Our specialized training programs equip clinicians and technicians with the expertise to master CAR T-cell therapy protocols and procedures.
Read our Articles and Meet Our Doctors.
CAR T-Cell Vectors
CD19 Vectors
Proven efficacy in B-cell malignancies with extensive research and clinical validation, significantly improving patient outcomes in leukemia and lymphoma treatments.
Find out moreCD22 Vectors
Specifically engineered to overcome resistance in B-cell therapy, demonstrating clinical success in challenging cases with improved response rates for blood cancer patients.
Find out moreBCMA Vectors
Advanced vector solution specifically designed for multiple myeloma treatment, demonstrating remarkable efficacy through clinical validation and success.
Find out moreCAR T-Cell Therapy Solutions
Supply of High-Quality Vectors
Premium CAR T-cell therapy vectors targeting various cancer types
Vector Preparation
Comprehensive protocols for vector preparation and handling procedures
Storage & Handling
Optimal storage conditions and specialized handling procedures
Technical Specialist Training
Hands-on training for biotechnologists and laboratory technicians
Physician Training
Comprehensive training for physicians in CAR T-cell therapy administration
Quality Control Training
Ensuring adherence to international quality standards and protocols
Clinical Issue Resolution
Expert support for clinical challenges and treatment complications
Regular Updates
Continuous updates on the latest CAR T-cell advancements and protocols
Program Scaling Support
Assistance with expanding your CAR T-cell therapy program capabilities
Integrated Management of CAR T-Cell Therapy Projects
We go beyond CAR T-cell therapy production to help cancer centers establish complete CAR T laboratories. Our comprehensive approach covers staff training, equipment procurement, laboratory setup, and infusion center design, managing every aspect of the technology transfer process.
Our dedicated team provides end-to-end support, ensuring your facility can successfully implement and maintain a state-of-the-art CAR T-cell therapy program with optimal efficiency and patient outcomes.
Contact Us for a Detailed Project Plan
Research & Publications
Our collaborative research has been presented at prestigious EHA and ASH conferences and published in leading journals including Frontiers in Immunology and other peer-reviewed publications.
Read More in Our BlogFrequently Asked Questions
CAR T-cell therapy vectors are specially engineered viral vectors that genetically modify a patient's T cells to precisely target and eliminate cancer cells. These vectors are fundamental to CAR T-cell therapy development, representing a revolutionary treatment approach for hematological malignancies including leukemia, lymphoma, and multiple myeloma.
Learn more about CAR T Therapy and Blood Cancer treatments.
We provide comprehensive technology transfer services including specialized training for biotechnologists and physicians in vector handling (storage, preparation, administration), regulatory compliance assistance, and continuous technical support (both on-site and remote) to ensure seamless implementation of your CAR T-cell therapy program.
Explore our Treatment Services and Hospital Partnerships.
Our implementation support includes comprehensive staff training, workflow optimization, best practice recommendations, continuous technical assistance for issue resolution, and regular updates on the latest CAR T-cell therapy advancements and protocol improvements.
Read about our Medical Team and Success Stories.
The technology transfer duration varies based on project complexity and existing infrastructure. Typically, the complete process requires 6 to 12 months, encompassing training, facility setup, protocol implementation, and validation phases to ensure program success.
Contact us for a Personalized Evaluation.
Yes, we conduct thorough assessments of your current infrastructure, provide detailed modification recommendations, and assist with process adaptation to seamlessly integrate CAR T-cell therapy into your existing laboratory setup while maintaining operational efficiency.
Learn about our Medical Tourism Services.